Home › Funds › KBC Group NV › IQV

KBC Group NV position in IQV

IQVIA HLDGS INC · Health Care

KBC Group NV reported holding 739,780 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$198.9M, representing 0.42% of its reported portfolio and ranking #40 among its reported holdings. KBC Group NV has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)739.78K sh
Reported value held$198.89M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How KBC Group NV's IQV position evolved

KBC Group NV first disclosed a stake in IQV in Q3 2023 at 43,686 shares (US$8.6M). The position peaked in Q3 2026 at 739,780 shares, worth US$198.9M. Across 13 filings, KBC Group NV increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 739,780 shares valued at US$198.9M — a reduction of -8,194 shares quarter over quarter.. Notable position changes include a 525% increase in Q4 2023 (shares rose 9% over the following quarter), a 127% increase in Q1 2024 (shares fell 16% over the following quarter), a 68% increase in Q4 2024 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 43.69K $8.60M New
Q4 2023 272.93K $63.15M Add
Q1 2024 620.53K $156.93M Add
Q2 2024 625.20K $132.19M Add
Q3 2024 365.84K $86.69M Reduce
Q4 2024 616.30K $121.11M Add
Q1 2025 603.75K $106.44M Reduce
Q2 2025 458.07K $72.19M Reduce
Q3 2025 463.25K $87.99M Add
Q4 2025 779.13K $175.62M Add
Q1 2026 774.06K $132.01M Reduce
Q2 2026 747.97K $144.52M Reduce
Q3 2026 739.78K $198.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IQV and 13F data

IQV (IQVIA HLDGS INC) is a Health Care company. 25 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Boston Partners (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IQV

All IQV fund holders →

FAQ

How long has KBC Group NV held IQV?

KBC Group NV has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is KBC Group NV's current position in IQV?

As of Q3 2026, KBC Group NV holds 739.78K shares of IQV (IQVIA HLDGS INC), valued at $198.89M, representing 0.42% of its reported portfolio and ranking #40.

Has KBC Group NV been buying or selling IQV?

In the latest 13F filing (Q3 2026), KBC Group NV reduced its position in IQV. The position peaked in Q3 2026 at 739.78K shares.

Which other funds hold IQV?

Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Boston Partners, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.